Blog
RSS FeedPosted by Michael Wonder on 16 Nov 2016
Trump should be good medicine for the pharmaceutical industry. Here’s why
15 November 2016 - The holidays came early for the pharmaceutical industry this year. ...
Posted by Michael Wonder on 16 Nov 2016
AMA embraces value-based drug pricing
15 November 2016 - The US' largest physician organisation is supporting value-based pricing for medications. ...
Posted by Michael Wonder on 16 Nov 2016
Study shows promise for expensive cholesterol drugs, but they are still hard to obtain
15 November 2016 - If there is one thing decades of studies with tens of thousands of heart disease patients ...
Posted by Michael Wonder on 16 Nov 2016
Republican lawmakers are scrambling to find an alternative to Obamacare
16 November 2016 - Congress is poised to repeal the Affordable Care Act. What might replace it? ...
Posted by Michael Wonder on 16 Nov 2016
ARMO BioSciences’ immunotherapy AM0010 receives orphan drug and fast track designations from the U.S. FDA for the treatment of pancreatic cancer
14 November 2016 - ARMO BioSciences announced that the U.S. FDA has granted the Company’s lead investigational immuno-oncology drug AM0010 ...
Posted by Michael Wonder on 15 Nov 2016
Trump just dropped a big hint to the pharmaceutical industry
14 November 2016 - A single sentence in President-elect Donald Trump's health-care platform sends a strong hint to the drug ...
Posted by Michael Wonder on 15 Nov 2016
What could be worse than repealing all of Obamacare?
14 November 2016 - Donald J. Trump made headlines on Friday by saying he would like to keep two components ...
Posted by Michael Wonder on 15 Nov 2016
Eagle Pharmaceuticals initiates rolling submission of NDA for Ryanodex in exertional heat stroke
11 November 2016 - Eagle Pharmaceuticals today announced that the Company has initiated the rolling submission of its new drug application ...
Posted by Michael Wonder on 14 Nov 2016
Pharma's not off the hook for high drug prices
15 November 2016 - Drug makers and insurers hold talks to come up with solutions. ...
Posted by Michael Wonder on 14 Nov 2016
Novartis drug PKC412 (midostaurin) granted FDA priority review for newly-diagnosed FLT3-mutated AML and advanced systemic mastocytosis
14 November 2016 - The AML treatment strategy has remained unchanged for more than 25 years and PKC412 (midostaurin) may ...
Posted by Michael Wonder on 13 Nov 2016
A precision medicine approach to clinical trials
14 November 2016 - Five or 6 years ago, only 5% to 10% of patients at David Hong's clinic arrived with ...
Posted by Michael Wonder on 13 Nov 2016
Knowing when and how to use medical products: a shared responsibility for the FDA and CMS
7 November 2016 - Before a medical product can be widely used in the United States, it generally must first be ...
Posted by Michael Wonder on 13 Nov 2016
U.S. FDA approves Gilead’s Vemlidy (tenofovir alafenamide fumarate) for the treatment of chronic hepatitis B virus infection
10 November 2016 - Vemlidy is a once-daily treatment that demonstrated similar efficacy with improved renal and bone laboratory safety ...
Posted by Michael Wonder on 13 Nov 2016
Donald Trump says he may keep parts of Obama Health Care Act
11 November 2016 - Just days after a national campaign in which he vowed repeatedly to repeal President Obama’s signature ...
Posted by Michael Wonder on 13 Nov 2016
HHS watchdog office steps up focus on drug pricing
10 November 2016 - Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department of ...